ResearcherFirst Hospital of China Medical UniversityNo recent work listed
Liping Zhou
Matched on ORCID iD 0000-0002-5670-2373; OpenAlex author ID A5101782458.
Their work
Counts cover pancreatic cancer work only: a researcher’s other papers, trials and grants are not in these records.
- Pancreatic cancer papers
- 3 (first author 0, last author 3)
- Pancreatic cancer trials
- 0
- Pancreatic cancer grants
- 0
- Labs led
- 1
- Collaborators
- 1
2020: 1 paper · 2021: none · 2022: 1 paper · 2023: 1 paper
Papers 3
- Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreatic cancer. Last author DOI 10.1038/s41598-023-44506-8↗
- The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma. Last author DOI 10.1186/s12885-022-09577-2↗
- Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcinoma. Last author DOI 10.1155/2020/8825997↗
Closest collaborators
The 1 strongest of 1 ranked by shared papers, trials and grants, with recent and small-team work weighing most.
- Hong Luan · 3 shared papers, 2020–2023
- Paper Identification of novel therapeutic target and prognostic biomarker in matrix metalloproteinase gene family in pancreat… DOI 10.1038/s41598-023-44506-8↗
- Paper The identification of liver metastasis- and prognosis-associated genes in pancreatic ductal adenocarcinoma. DOI 10.1186/s12885-022-09577-2↗
- Paper Identification of Key Prognostic Biomarker and Its Correlation with Immune Infiltrates in Pancreatic Ductal Adenocarcin… DOI 10.1155/2020/8825997↗
How to reach this person
A chain of introductions through people who have published, run trials or held grants together (the fewest links first, then the links with the most shared work). Built from public records only; no contact details are kept.